MORE THAN A DECADE OF PROTECTION WITH PREVENAR 13®1,2
The MOH NCIS recommends 2 primary doses and 1 booster dose of Prevenar 13® for infants aged 0 to 12 months.3
Prevenar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) is a vaccine indicated for children 6 weeks through 17 years of age for the prevention of pneumococcal pneumonia and invasive disease caused by 13 streptococcus pneumoniae strains (1, 3, 4, 5, 6A, 7F, 9V, 14, 18C, 19A, 19F and 23F).4
MORE THAN A DECADE OF PROTECTION WITH PREVENAR 13®1,2
The MOH NCIS recommends 2 primary doses and 1 booster dose of Prevenar 13® for infants aged 0 to 12 months.3
Prevenar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) is a vaccine indicated for children 6 weeks through 17 years of age for the prevention of pneumococcal pneumonia and invasive disease caused by 13 streptococcus pneumoniae strains (1, 3, 4, 5, 6A, 7F, 9V, 14, 18C, 19A, 19F and 23F).4
© 2021 Pfizer Pte Ltd. All rights reserved.
The information provided in this site is intended only for Healthcare Professionals in Singapore. The products discussed herein may have different product labelling in different countries. Pfizer Pte Ltd, Singapore is a subsidiary of Pfizer Inc, a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.
